Amphastar Pharmaceuticals, Inc
SWB:29A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Amphastar Pharmaceuticals, Inc
SWB:29A
|
US |
|
S
|
Sanko Diecasting Thailand PCL
SET:SANKO
|
TH |
|
K
|
K&S AG
DUS:SDF
|
DE |
|
G
|
Golden Spike Resources Corp
CNSX:GLDS
|
CA |
|
LCL Resources Ltd
ASX:LCL
|
AU |
|
T
|
Thurgauer Kantonalbank
F:TK2A
|
CH |
|
Beam Global
NASDAQ:BEEM
|
US |
|
Impero A/S
F:905
|
DK |
|
T
|
Trifork Holding AG
CSE:TRIFOR
|
CH |
|
Bayan Mining and Minerals Ltd
ASX:BMM
|
AU |
|
H
|
Harbour-Link Group Bhd
KLSE:HARBOUR
|
MY |
|
M
|
MI Technovation Bhd
KLSE:MI
|
MY |
|
Janison Education Group Ltd
ASX:JAN
|
AU |
Bankruptcy Probability
Amphastar Pharmaceuticals, Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Amphastar Pharmaceuticals, Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Amphastar Pharmaceuticals, Inc
NASDAQ:AMPH
|
1.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
620.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
382.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
370B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
201.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
289.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
170.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Amphastar Pharmaceuticals, Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Amphastar Pharmaceuticals, Inc has total debt of 609.6m USD. This includes both short-term (0 USD) and long-term (609.6m USD) debt.
You can find a full breakdown on its Balance Sheet.